Correlation Between Institute and Eledon Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Institute and Eledon Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Institute and Eledon Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Institute of Biomedical and Eledon Pharmaceuticals, you can compare the effects of market volatilities on Institute and Eledon Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Institute with a short position of Eledon Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Institute and Eledon Pharmaceuticals.

Diversification Opportunities for Institute and Eledon Pharmaceuticals

0.16

Correlation Coefficient

Institute  Eledon Pharmaceuticals

Average diversification

The 3 months correlation between Institute and Eledon is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Institute of Biomedical and Eledon Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eledon Pharmaceuticals and Institute is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Institute of Biomedical are associated (or correlated) with Eledon Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eledon Pharmaceuticals has no effect on the direction of Institute i.e., Institute and Eledon Pharmaceuticals go up and down completely randomly.

Pair Corralation between Institute and Eledon Pharmaceuticals

Given the investment horizon of 90 days Institute of Biomedical is expected to generate 2.78 times more return on investment than Eledon Pharmaceuticals. However, Institute is 2.78 times more volatile than Eledon Pharmaceuticals. It trades about 0.1 of its potential returns per unit of risk. Eledon Pharmaceuticals is currently generating about 0.21 per unit of risk. If you would invest  0.55  in Institute of Biomedical on September 12, 2024 and sell it today you would earn a total of  0.25  from holding Institute of Biomedical or generate 45.45% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	98.44%
Values	Daily Returns

Institute of Biomedical  vs.  Eledon Pharmaceuticals

Institute of Biomedical

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Institute of Biomedical are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak technical and fundamental indicators, Institute unveiled solid returns over the last few months and may actually be approaching a breakup point.

Eledon Pharmaceuticals

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Eledon Pharmaceuticals are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, Eledon Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Institute and Eledon Pharmaceuticals

The main advantage of trading using opposite Institute and Eledon Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Institute position performs unexpectedly, Eledon Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eledon Pharmaceuticals will offset losses from the drop in Eledon Pharmaceuticals' long position.

The idea behind Institute of Biomedical and Eledon Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.